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ABSTRACT
Purpose: Non-ambulatory persons with cerebral palsy are prone to low bone mineral density. In ambula-
tory persons with cerebral palsy, bone mineral density deficits are expected to be small or absent, but a
consensus conclusion is lacking. In this systematic review bone mineral density in ambulatory persons
with cerebral palsy (Gross Motor Function Classification Scales I–III) was studied.
Materials and methods: Medline, Embase, and Web of Science were searched. According to international
guidelines, low bone mineral density was defined as Z-score2.0. In addition, we focused on Z-score-
1.0 because this may indicate a tendency towards low bone mineral density.
Results: We included 16 studies, comprising 465 patients aged 1–65 years. Moderate and conflicting evi-
dence for low bone mineral density (Z-score2.0) was found for several body parts (total proximal
femur, total body, distal femur, lumbar spine) in children with Gross Motor Function Classification Scales II
and III. We found no evidence for low bone mineral density in children with Gross Motor
Function Classification Scale I or adults, although there was a tendency towards low bone mineral density
(Z-score1.0) for several body parts.
Conclusions: Although more high-quality research is needed, results indicate that deficits in bone mineral
density are not restricted to non-ambulatory people with cerebral palsy.
 IMPLICATIONS FOR REHABILITATION
 Although more high-quality research is needed, including adults and fracture risk assessment, the cur-
rent study indicates that deficits in bone mineral density are not restricted to non-ambulatory people
with CP.
 Health care professionals should be aware that optimal nutrition, supplements on indication, and an
active lifestyle, preferably with weight-bearing activities, are important in ambulatory people with CP,
also from a bone quality point-of-view.
 If indicated, medication and fall prevention training should be prescribed.
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Introduction
Cerebral palsy (CP) occurs in 1.5–3.0 out of every 1000 live
births and is the most common cause of physical disability in
pediatric rehabilitation medicine [1]. CP describes a group of
permanent disorders in the development of movement and pos-
ture causing limitations in activity that are attributable to non-
progressive disturbances which occurred in the fetal or infant
brain [2]. There are three CP subtypes: spastic, ataxic, and dyski-
netic [1]. Motor disorders of CP are often accompanied by dis-
turbances of sensation, perception, cognition, communication,
and behavior, as well as epilepsy and secondary musculoskeletal
problems [2]. Moreover, persons with CP often have nutritional
problems [3,4].
Persons with CP are prone to low bone mineral density (BMD)
[3,5] because of low calcium and vitamin D intake [3,5,6] as well
as use of anticonvulsant medication [3,7], which can lead to vita-
min D deficiency [5]. Furthermore, persons with CP are generally
known to have inactive lifestyles [8–11], which may adversely
affect BMD [7].
Several studies [3,12–17], including two systematic reviews
[16,17], have suggested the presence of low BMD in children, ado-
lescents, and adults with CP. However, these studies mainly
focused on non-ambulatory persons with moderate to severe CP
(Gross Motor Function Classification System (GMFCS) levels IV–V
[18]). Because nutritional deficiencies, epilepsy [19], and inactivity
[10] occur less frequently or less severely in persons with CP who
are ambulatory or mildly affected (GMFCS levels I–III), it may be
expected that BMD deficits are smaller or absent in these sub-
groups. Furthermore, ambulatory persons perform more weight-
bearing activities compared to non-ambulatory persons, which
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may prevent development of low BMD [9]. However, evidence for
the magnitude of BMD deficits in ambulatory persons with CP is,
as far as we know, lacking. BMD information in this subgroup is
important because it may have treatment implications.
The aim of this systematic review was to provide an overview
of the current scientific literature on BMD in ambulatory persons
(children and adults) with mild to moderate CP (GMFCS lev-
els I–III).
Materials and methods
Literature search
This study focusing on BMD in ambulatory persons with CP
(GMFCS levels I–III) was a computer-aided literature study per-
formed using Medline, Embase, and Web of Science up to June
2017. Key words representing CP and BMD were included in the
literature search. The complete search strategy is shown in
Supplementary Table S1.
Inclusion criteria
Full-text original studies (i.e., no abstracts, reviews or editorials)
were included in this study if they fulfilled all of the following cri-
teria: (1) study of a diagnostic group of CP classified as GMFCS
levels I–III. Studies also including GMFCS levels IV and V were per-
mitted if results for GMFCS levels I–III were presented separately
or results for GMFCS levels I–III could be calculated separately; (2)
BMD was included as an outcome measure; (3) the study had to
be an observational study (cohort study or case–control study) or
concern baseline measurements of an intervention or experimen-
tal study; (4) results on BMD had to be compared with reference
data and presented as average Z-score (standard deviation (SD)).
A Z-score is the difference between a patient’s value and an age-
specific mean value, divided by the reference group’s SD.
Alternatively, the average Z-score (SD) for persons with CP could
be calculated from results of BMD in a simultaneously measured
control group of typically developing persons (case control stud-
ies). For proper calculation, a minimum sample size of typically
developing persons was set at 15; and (5) the study had to be
written in English, German, French, or Dutch.
Study selection
Two reviewers (C. M. and R. v. d. B.) independently selected
potentially relevant studies using the inclusion criteria to evaluate
titles, abstracts, and full text articles (Figure 1). A consensus
method was used when there was any disagreement regarding
the inclusion of the data between the two reviewers. When any
disagreement persisted, a third reviewer (B. H.) was consulted. In
the case of multiple articles by the same authors, we contacted
corresponding authors to clarify whether the articles used differ-
ent study samples.
Data extraction
The same two reviewers independently extracted the data from
included studies. Any disagreement about data extraction was
resolved by the same consensus process as previously described.
Characteristics of the included studies can be found in
Supplementary Table S2.
Methodological quality assessment
The two reviewers (C. M. and R. v. d. B.) independently assessed
the methodological quality of the included studies using a con-
structed quality assessment list (Table 1), which included criteria
adapted from the New Castle-Ottawa scale [20], the Dutch
Cochrane Centre [21], as well as the studies of Huisstede et al.
[22,23], Van Rijn et al. [24,25], and Hombergen et al. [26] and
modified to cover the topic of this review. The list consisted of
ten items within three themes (study population/selection, out-
come measurements, and study design). The reviewers scored
each item as positive (þ), negative (), or unclear (?). A consensus
procedure was used to resolve disagreements between reviewers.
A study was considered high-quality when the score exceeded
50% of the maximum attainable score.
Data analysis
We considered pooling of data in a meta-analysis when patient
characteristics and outcome measures used to evaluate BMD were
homogeneous. If pooling of data was not possible, a best-evi-
dence synthesis was performed to summarize the results of the
included studies. For the best-evidence synthesis, we used Z-score
to compare the results between persons with CP and typically
developing persons. According to the International Society For
Clinical Densitometry [6,27], low BMD was defined as a Z-score-
2 for our primary evidence synthesis. We adopted this defin-
ition for both children and adults with CP. In addition, we focused
on Z-score1.0, because this may indicate a tendency towards
low BMD. For (case–control) studies that did not provide Z-score,
we calculated average (SD) Z-score based on average BMD level
in the CP group and average (SD) BMD level in the simultaneously
measured control group of typically developing persons (the min-
imum requested sample size of typically developing persons was
set at 15). If levels of significance were not provided for the com-
parisons of our interest, we calculated p values using means, SDs,
and sample sizes.
The level of evidence for low BMD in persons with CP was
ranked as follows [26]: (1) Strong evidence:  2 high-quality stud-
ies in which CP results meet the criteria for low BMD (i.e., an aver-
age BMD Z-score –2.0) and differ significantly (p 0.05) from
typically developing persons results; (2) moderate evidence:  2
low-quality studies or 1 high-quality study in which CP results
meet criteria for low BMD (i.e., an average BMD Z-score –2.0)
and differ significantly (p 0.05) from typically developing persons
results; (3) limited evidence: 1 low-quality study in which CP
results meet the criteria for low BMD (i.e., an average BMD
Z-score2.0) and differ significantly (p 0.05) from typically
developing persons results; (4) conflicting evidence: conflicting
findings between studies (less than 75% of studies report low
BMD in the CP group compared with the typically developing per-
sons group and a significant difference between the results in the
CP and the typically developing persons group); (5) no evidence:
studies available, but no low BMD or no significant differences
between the CP and typically developing persons groups are
reported; (6) no studies found.
In addition, as a secondary best-evidence synthesis, we applied
the above ranking method for the cutoff level of Z-score1.0,
since this level may indicate a tendency towards low BMD.
Results (mean and SD, where necessary, SD was calculated
from standard error [SE]) were described for each body site separ-
ately (lumbar spine [comprising several spinal levels], total prox-
imal femur, femur neck, distal femur, calcaneus, radius, and tibia),
and for the total body. Furthermore, we reported results for
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children (age 0–17 years) and adults (18 years) and for each
GMFCS level separately. If this was not possible, we described
results for combined age (including both children and adults) and
combined ambulatory levels (GMFCS levels I and II or GMFCS lev-
els I–II–III). To enhance readability, we only reported Z-score-
s2.0 and Z-scores1.0 in the results section. Of course, the
best-evidence syntheses were based on all Z-scores, including
those>1.0; an overview of all Z-scores can be found in Tables
4–6. Because of small sample sizes, results at the alpha level of
0.10 were reported.
Results
Characteristics of included studies
The literature search resulted in 1330 potentially eligible studies.
After reviewing titles, abstracts, and full text-articles, 19 studies
met our inclusion criteria (Figure 1). For three studies by
Henderson et al. [3,13,28] and three studies by Chen et al.
[29–31], there was uncertainty about whether these studies
reported on the same study sample. Consultation with the authors
revealed that the studies of Henderson et al. reported on one
study sample; therefore, only one study [3] was included in this
review. We did not succeed in contacting the group of Chen. We
decided to include the GMFCS level I and II results for the lumbar
spine and femur, as reported in one of their studies [31].
Furthermore, we included part of another study by Chen et al.
[30] that focused on GMFCS level III and the calcaneus results. In
total, 16 studies were included in the analysis.
The study of Esen et al. [32] reported Z-score for four different
adjustment methods (decimal age, bone age, height age, and
height-for-age). According to the recommendation of the
International Society for Clinical Densitometry [27] to use if pos-
sible the Z-score adjusted for height, we decided to report only
the Z-score adjusted for height. The Society also recommends
measuring BMD in the total proximal femur or femur neck and
not in the greater trochanter or Ward’s triangle [6,27]. Therefore,
we did not report the results measured in these latter regions in
the study of Han et al. [33] and Kim et al. [34]. Because most
Search
Medline: 412 Embase: 897 Web of Science: 628 
Potential relevant articles 
identified, after duplicates 
removed: 1330
Excluded based on 
title/abstract: 1093 
Remaining articles 
reviewed for more 
detailed information: 237
Excluded after full text 
evaluation: 218 
Articles derived from 
reference lists: 0 
Studies meeting 
inclusion criteria: 19 
Studies included in 
review: 16 
Excluded, because 
reporting on the same 
study sample: 3 
Figure 1. Flowchart of the included studies.
2394 C. T. R. MUS-PETERS ET AL.
studies of the distal femur measured BMD in region 2 (mixture of
cortical and trabecular bone), we report only results for region 2.
Characteristics of the included studies are presented in
Supplementary Table S2. The included studies comprised a total
of 465 persons with CP (GMFCS I–III) ranging in age from 1 to
65 years. Ten studies used reference data to interpret BMD in CP
(Z-score) and six studies had a case–control design from which we
calculated Z-score. Pooling of the results was not possible because
of heterogeneity in patient characteristics and outcome measure-
ments. Fourteen studies reported BMD results of the lumbar spine
[3,12,30–41], nine of the femur [3,12,30,31,33,34,37,38,42], two of
the calcaneus [30,36], two of the total body [37,42], and one of
the radius and tibia [43]. Most studies focused on children, but
five focused on adults [34,38,39] or a mixed age group [3,43]. The
countries from which the participants were recruited were:
Canada [3,12,42], Taiwan [30,31], USA [3,39], England [36], Turkey
[32], Norway [37], Korea [33], Israel [43], and Pakistan [41]. Four
studies did not report the country from which the participants
were recruited [34,35,38,40]. Five studies [12,30,31,40,42] reported
only on persons with spastic CP, three studies [34,37,38] on other
types of CP, and seven studies [3,32,33,35,36,39,41,43] did not
report CP type.
Almost all studies used dual X-ray absorptiometry scan for
measuring BMD. Three studies used quantitative computed tom-
ography (QCT) [35,36,39] and three studies used ultrasound of the
calcaneus [30,36], or radius and tibia [43].
Methodological quality
The methodological quality results are shown in Table 2. Ten stud-
ies (63%) were classified as high-quality [3,12,30,31,35,37,38,40–42]
and six (37%) as low-quality [32–34,36,39,43]. The most common
methodological shortcomings were (1) study samples that were
not consecutive or an obviously representative series of cases
(88%); and (2) the total number of cases was less than 50 (63%).
Bone mineral density results
Lumbar spine
GMFCS I. Five high-quality studies [12,31,35,37,41] reported BMD
results of the lumbar spine in children classified as GMFCS level I
(Tables 3 and 4). An exact lumbar spine level was not reported.
According to Z-score2.0, there was no low BMD noted.
However, Akhter et al. [41] reported an average Z-score of 1.30
(SD 0.09, p< 0.0001). According to the best-evidence synthesis
regarding Z-score2.0, there was no evidence for low BMD.
Regarding Z-score1.0, there was conflicting evidence for low
BMD of the lumbar spine in children with GMFCS level I.
We found no studies of BMD of the lumbar spine in adults
with GMFCS level I (Tables 5 and 6).
GMFCS II. Five high-quality studies [12,31,35,37,41] reported BMD
results of the lumbar spine in children classified as GMFCS level II
(Tables 3 and 4). According to Z-score2.0, none of these stud-
ies found low BMD. However, Akhter et al. [41] reported an aver-
age Z-score of 1.68 (SD 0.33, p< 0.0001) and Finbråten et al.
[37] of 1.4 (SD 1.3, p< 0.01). According to the best-evidence syn-
thesis regarding Z-score2.0, there was no evidence for low
BMD. Regarding Z-score1.0, there was conflicting evidence for
low BMD of the lumbar spine in children with GMFCS level II. We
found no studies of BMD of the lumbar spine in adults with
GMFCS level II (Tables 5 and 6).
GMFCS III. Four high-quality studies [12,30,35,41] and two low-
quality studies [33,36] reported BMD of the lumbar spine in chil-
dren with GMFCS level III (Tables 3 and 4). Regarding Z-score-
2.0, the low-quality study of Wilmshurst et al. [36] reported
low BMD at T12-L3 (Z-score 2.12, SD 1.2, p< 0.05). Furthermore,
the high-quality studies of Akhter et al. [41] (Z-score 1.86, SD
0.20, p< 0.0001) and Chen et al. [30] (Z-score 1.1, SD 0.6,
p< 0.01; L1–L4) reported Z-score1.0. According to the best-
evidence synthesis regarding Z-score2.0 and regarding Z-
score1.0, there was conflicting evidence for low BMD of the
lumbar spine in children with GMFCS level III (Table 3).
Table 1. Quality assessment criteria.
Study population/selection
1. Positive if samples are consecutive or an obviously representative series of persons with cerebral palsy (recruitment from more than one hospital or rehabilita-
tion centre)
2. Sufficient description of characteristics of persons with CP
Positive if at least four out of six requirements are reported
(a) Age (mean and standard deviation or range)
(b) Sex (number or percentage)
(c) Type of cerebral palsy
(d) Distribution of cerebral palsy
(e) Level of ambulation
(f) Level of intelligence/education
3. Sufficient description of characteristics of typically developing persons
Positive if at least two out of three requirements are reported:
(a) Age (mean and standard deviation or range)
(b) Sex (number or percentage)
(c) Level of intelligence/education
4. Positive if participation in bone mineral density (BMD) measurements is 70% in persons with CP and typically developing persons
5. Positive if the total number of cases is 50 (25 persons with CP and 25 typically developing persons)
Outcome measurements
6. Positive if BMD measurements are obtained in a standardized valid way
Study design
7. Positive if inclusion and exclusion criteria are described for persons with CP
8. Positive if inclusion and exclusion criteria are described for typically developing persons
9. Positive if potential confounders are described (medication for epilepsy, nutrition and sports activity) and BMD data are matched/adjusted for these confounders
10. Positive if persons with CP and typically developing persons are matched for age and sex in the design or adjusted for these factors in the analysis
CP: cerebral palsy; BMD: bone mineral density.
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In the high-quality study by Henderson et al. [3], which
included persons up to 19 years of age, BMD lumbar spine results
were reported for GMFCS level III (Tables 3 and 5). Regarding
Z-score2.0, no low BMD of the lumbar spine was noted.
However, Henderson et al. [3] reported a Z-score of 1.5 (SD 0.9,
p< 0.001; lumbar spine level was not reported). According to the
best-evidence synthesis regarding Z-score2.0, there was no
evidence for low BMD. Regarding Z-score1.0, there was mod-
erate evidence for low BMD of the lumbar spine in a combined
group of children and adults up to 19 years of age at GMFCS
level III.
The high-quality study by Fowler et al. [38] reported BMD
results of the lumbar spine (spine level not reported) in adults
with GMFCS level III (Tables 3 and 6); no low BMD was reported,
neither regarding Z-score2.0 nor regarding Z-score1.0).
According to the best-evidence synthesis (both regarding Z2.0
and regarding Z1.0), there was no evidence for low BMD of
the lumbar spine in adults with GMFCS level III.
GMFCS I II combined. Two low-quality studies [33,36] reported
BMD of the lumbar spine in children with combined GMFCS levels
I and II (Tables 3 and 4). None of these studies reported low BMD
according to Z-score2.0. However, Wilmshurst et al. [36]
reported a Z-score of 1.08 (SD 0.9, p< 0.05; T12-L3). According
to the best-evidence synthesis regarding Z-score2.0, there was
no evidence for low BMD. Regarding Z-score1.0, there was
conflicting evidence for low BMD of the lumbar spine in children
within the combined GMFCS levels I and II group.
The high-quality study by Fowler et al. [38] reported BMD
results of the lumbar spine (lumbar spine level not reported) in
adults with GMFCS levels I and II combined (Tables 3 and 6); no
low BMD was reported according to Z-score2.0; however, they
reported a Z-score of 1.07, (SD 1.0, p< 0.001). According to the
best-evidence synthesis regarding Z-score2.0, there was no
evidence for low BMD. Regarding Z-score1.0, there was mod-
erate evidence for low BMD of the lumbar spine in adults of a
group with GMFCS levels I and II combined.
GMFCS I–II–III combined. Two high-quality studies [37,40] and one
low-quality study [32] reported BMD results of the lumbar spine in
a combined group of children with GMFCS levels I, II, and III
(Tables 3 and 4). None of the studies reported low BMD according
to Z-score2.0. However, the low-quality study of Esen et al.
[32] reported an average Z-score of 1.21 at L1–L4 (SD 1.4,
p< 0.001). According to the best-evidence synthesis regarding Z-
score2.0, there was no evidence for low BMD. Regarding Z-
score1.0, there was conflicting evidence for low BMD of the
lumbar spine in a combined group of children with GMFCS levels
I, II, and III.
Two low-quality studies [34,39] reported BMD results of the
lumbar spine in adults with GMFCS levels I, II, and III combined
(Tables 3 and 6). Kim et al. [34] reported the results separately for
the spastic type and dyskinetic type of CP without mentioning if
the BMD was measured in trabecular or in cortical bone of the
lumbar vertebras. The study of Peterson et al. [39] reported the
results separately for trabecular and cortical bone without men-
tioning the type of CP. No low BMD was noted, neither regarding
Z-score2.0 nor regarding Z-score1.0. According to the
best-evidence synthesis (both regarding Z-score2.0 and
regarding Z-score1.0), there was no evidence for low BMD of
the lumbar spine in adults with GMFCS levels I, II, and
III combined.Ta
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Femur
Total proximal femur. Two high-quality studies, one by Henderson
et al. [12] and one by Chad et al. [42], reported BMD of the total
proximal femur in children with different GMFCS levels (Tables 3
and 4). Regarding Z-score2.0, Henderson et al. [12] reported
low BMD in children with GMFCS level III (Z-score of 2.3 SD 1.2,
p< 0.001). For GMFCS level I, GMFCS level II, and GMFCS levels I
and II combined, no low BMD was reported, neither regarding Z-
score2.0 nor regarding Z-score1.0 [12,42]. According to
the best-evidence synthesis regarding Z-score2.0 and regard-
ing Z-score1.0, there was moderate evidence for low BMD of
the total proximal femur in children with GMFCS level III. There
was no evidence (not regarding Z-score2.0 nor regarding Z-
score1.0) for low BMD of the total proximal femur in children
with GMFCS level I, II, or in a group with GMFCS levels I and
II combined.
One high-quality study by Fowler et al. [38] and one low-qual-
ity study by Kim et al. [34] reported BMD results of the total prox-
imal femur in adults with different GMFCS levels (Tables 3 and 6).
None of these studies reported low BMD according to Z-score-
2.0. However, the high-quality study of Fowler et al. [38]
reported in GMFCS level III a Z-score of 1.23 (SD 0.9, p< 0.01)
and the low-quality study of Kim et al. [34] reported in GMFCS
levels I–II–III combined (spastic type) a Z-score of 1.2, (SD 1.0,
p¼ 0.001). According to the best-evidence synthesis regarding Z-
score2.0, there was no evidence for low BMD in the group of
adults with GMFCS levels I and II combined, GMFCS level III, and
adults with spastic and dyskinetic type of CP with GMFCS levels I,
II, and III combined. According to the best-evidence synthesis
regarding Z-score1.0, there was moderate evidence for low
BMD of the total proximal femur in adults with GMFCS level III
and limited evidence for low BMD of the total proximal femur in
adults with spastic type of CP with GMFCS levels I, II and III com-
bined. In addition, according to the best-evidence synthesis
regarding Z-score1.0, there was no evidence for low BMD of
the total proximal femur in adults in a group with GMFCS level I
and II combined, as well as in adults with dyskinetic type of CP
with GMFCS levels I, II, and III.
Proximal femur: femur neck. The high-quality study by Chad et al.
[42] and the low-quality study by Han et al. [33] reported BMD of
the femur neck in children with different GMFCS levels (Tables 3
and 4). The low-quality study of Han et al. [33] reported in a
group with GMFCS levels I and II combined a Z-score of 1.0 (SD
0.6, p¼ 0.05). According to the best-evidence synthesis regarding
Z-score2.0, there was no evidence for low BMD of the femur
neck in children with GMFCS levels I and II combined or with
GMFCS level III. According to the best-evidence synthesis regard-
ing Z1.0, there was conflicting evidence for low BMD of the
femur neck in children with GMFCS levels I and II combined and
no evidence for children with GMFCS level III.
One high-quality study by Fowler et al. [38] and one low-qual-
ity study by Kim et al. [34] reported BMD of the femur neck in
adults with different GMFCS levels (Tables 3 and 6). No low BMD
was reported, neither regarding Z-score2.0 nor regarding Z-
score1.0. According to the best-evidence synthesis, there was
no evidence for low BMD of the femur neck in adults with GMFCS
level III, levels I and II combined, or levels I, II, and III combined,
both regarding Z-score2.0 and regarding Z score1.0.
Table 3. Evidence for low bone mineral density.
Study Year GMFCS
Lumbar
spine
Total
proximal
femur
Femur
neck
Distal femur
(region 2)
Distal femur
(no region) Calcaneus Radius Tibia
Total
body
Akhter [41] HQ 2017 I NE – – – – – – – –
II NE – – – – – – – –
III NE – – – – – – – –
Chad [42] HQ 2000 I–II – NE NE – – – – – NE
Chen [31] HQ 2011 I NE – – NE – – – – –
II NE – – NE – – – – –
Chen [30] HQ 2011 I–II – – – – – NE – – –
III NE – – – NE NE – – –
Finbråten [37] HQ 2015 I NE – – NE – – – – NE
II NE – – E – – – – E
I–II–III NE – – NE – – – – –
Fowler [38] HQ 2015 I–II NE NE NE – – – – – –
III NE NE NE – – – – – –
Henderson [12] HQ 1995 Ia NE NE – – – – – – –
IIa NE NE – – – – – – –
IIIa NE E – – – – – – –
Henderson [3] HQ 2002 III NE – – NE – – – – –
€Unay [40] HQ 2003 I–II–IIIa NE – – – – – – – –
Wren [35] HQ 2011 I NE – – – – – – – –
II NE – – – – – – – –
III NE – – – – – – – –
Esen [32] LQ 2011 I–II–III NE – – – – – – – –
Han [33] LQ 2012 I–IIa NE – NE – – – – – –
IIIf NE – NE – – – – – –
Hartman [43] LQ 2004 I – – – – – – NE NE –
II – – – – – – NE NE –
Kim [34] LQ 2015 I–II–III spastic NE NE NE – – – – – –
I–II–III dyskinetic NE NE NE – – – – – –
Peterson [39] LQ 2015 I–II–III trabecular NE – – – – – – – –
I–II–III cortical NE – – – – – – – –
Wilmshurst [36] LQ 1996 I–IIa NE – – – – NE – – –
IIIa E – – – – NE – – –
NE: no evidence for low BMD; E: evidence for low BMD (Z-score2.0); NE (Italics): no evidence for low BMD, but a tendency for low BMD (Z-score1.0); –: no
studies included in this category; HQ: high-quality study; LQ: low-quality study; GMFCS: Gross Motor Function Classification Scale.
aGMFCS level inferred from descriptions.
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Distal femur. Three high-quality studies [30,31,37] reported BMD
of the distal femur in children with different GMFCS levels (Tables
3 and 4). Two studies [31,37] reported BMD results in region 2
(mixture of cortical and trabecular bone); one study [30] did not
report the specific region of BMD measurement. For GMFCS
level I, no low BMD was reported, neither regarding Z-score-
2.0 nor regarding Z-score1.0. For GMFCS level II,
Finbråten et al. [37] reported low BMD (Z-score 2.8, SD 1.2,
p< 0.001), whereas Chen et al. [31] reported no low BMD
according to Z-score2.0. For GMFCS levels I, II, and III
combined, Finbråten et al. [37] reported no low BMD according
to Z-score2.0 (Z-score 1.6, SD 1.8, p< 0.001). According to
the best-evidence synthesis regarding Z-score2.0 and
Z-score1.0, there was conflicting evidence for low BMD of
the distal femur in children with GMFCS level II. Furthermore,
there was no evidence for low BMD of the distal femur in chil-
dren with GMFCS level I, GMFCS level III, or in a group
Table 4. Bone mineral density results for children.
Measurement location Ambulation and/or GMFCS Study Z-score (SD) p value
Proximal femur
Total proximal femur Normal (I) Henderson [12] 0.23 (1.1c) >0.05c
Community (II) Henderson [12] –0.8b (1.2c) 0.001c
Household (III) Henderson [12] –2.3b (1.2c) <0.001c
Independent (I–II) Chad [42] –0.23 (1.5) >0.05c
Femoral neck Independent (I–II) Chad [42] 0.13 (1.7) >0.05c
Independent (I–II) Han [33] –1c (0.6c) ¼0.05c
Walker (III) Han [33] –0.85c (0.3c) <0.10c
Distal femur
Region 2 I Chen [31] –0.38c (0.6c) <0.10cFinbråten [37] –0.7 (1.2) <0.05c
II Chen [31] –0.43c (0.5c) <0.10cFinbråten [37] –2.8 (1.2) <0.001c
I–III Finbråten [37] –1.6 (1.8) <0.001c
Region not reported III Chen [30] –0.77c (0.6) ¼0.05c
Lumbar spine
T12–L3 Mobile with abnormal gait (I–II) Wilmshurst [36] –1.08 (0.9c) <0.05c
Mobile with frame or rollator (III) Wilmshurst [36] –2.12 (1.2c) <0.05c
L1–L4 I Chen [31] –0.28c (0.8c) >0.05c
II Chen [31] –0.5c (0.8c) <0.10c
Independent (I–II) Han [33] –0.14c (1.4c) >0.05c
III Chen [30] –1.1c (0.6c) <0.01c
Walker (III) Han [33] 0.29c (1.6) >0.05c
I–II–III Esen [32] –1.21 (1.4) <0.001
L2–L4 Ambulant (I–III) €Unay [40] –0.43c (1.1) >0.05c
L3 I Wren [35] –0.04ac (1.1a,c) >0.05a,c
II Wren [35] –0.37ac (1.2a,c) >0.05a,c
III Wren [35] –0.45ac (0.9a,c) ¼0.05a,c
Not reported Normal (I) Henderson [12] –0.3b (1.2c) >0.05c
I Finbråten [37] –0.4d (1.1) >0.05cAkhter [41] –1.30 (0.09) <0.0001 c
Community (II) Henderson [12] –0.6b (0.7c) <0.001c
II Finbråten [37] –1.4d (1.3) <0.01cAkhter [41] –1.68 (0.33) <0.0001c
III Akhter [41] –1.86 (0.20) <0.0001c
Household (III) Henderson [12] –0.8b (0.9c) <0.05c
I–II–III Finbråten [37] –0.8 (1.2) <0.01c
Calcaneus Mobile with abnormal gait (I–II) Wilmshurst [36] –1.07 (1.0c) <0.01c
I–II Chen [30] –0.59c (0.5c) <0.05c
Mobile with frame or rollator (III) Wilmshurst [36] –1.85 (1.0) <0.05c
III Chen [30] –1.71c (0.7c) <0.001c
Total body I Finbråten [37] –1.5d (0.9) <0.001c
II Finbråten [37] –2.2d (1.1) <0.001c
Independent (I–II) Chad [42] –0.25 (1.4) >0.05c
aObtained from first author.
bInferred from figure.
cCalculated based on mean, standard deviation and sample size.
dAdjusted for height; studies indicated with a  demonstrate a high-quality study. Z-score2.0 are in bold. Additional Z-score1.0 are in italics; distal femur
region 2: transition between metaphysis and diaphysis (mixture of cortical and trabecular bone); GMFCS: Gross Motor Function Classification System [18].
Table 5. Bone mineral density results for combined groups of children
and adults.
Measurement location GMFCS Study Z-score (SD) p value
Distal femur
Region 2 III Henderson [3] 1.8 (1.3b) <0.001b
Tibia
Midshaft Ia Hartman [43] 0.6 (1.6) >0.05b
IIa Hartman [43] 0.5 (1.4) >0.05b
Lumbar spine
Not reported III Henderson [3] 1.5 (0.9b) <0.001b
Radius
Distal third Ia Hartman [43] 1.7 (0.5) <0.01b
IIa Hartman [43] 0.9 (1.3) <0.05b
aObtained from first author.
bCalculated based on mean, standard deviation and sample size; studies indi-
cated with a  demonstrate a high quality study. Additional Z-score1.0 are
in italics; distal femur region 2: transition between metaphysis and diaphysis
(mixture of cortical and trabecular bone); GMFCS: Gross Motor Function
Classification System [18].
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combining GMFCS levels I, II, and III regarding Z-score2.0.
According to the best-evidence synthesis regarding Z-score
1.0, there was moderate evidence for low BMD of the distal
femur in a group combining GMFCS levels I, II and III and no
evidence for low BMD for GMFCS levels I and III.
The high-quality study of Henderson et al. [3] reported distal
femur results (region 2, a mixture of cortical and trabecular
bone) in a sample that included persons up to 19 years of age
with GMFCS level III. Regarding Z-score2.0, no low BMD
was reported; however, Henderson et al. [3] reported a Z-score
of 1.8, (SD 1.3, p< 0.001). According to the best-evidence syn-
thesis regarding Z-score2.0, there was no evidence for low
BMD of the distal femur in a combined group of children and
adults up to 19 years of age with GMFCS level III. According to
the best-evidence synthesis regarding Z-score1.0, there was
moderate evidence for low BMD of the distal femur in a group
combining children and adults up to 19 years of age with
GMFCS level III.
Calcaneus
The high-quality study of Chen et al. [30] and the low-quality
study of Wilmshurst et al. [36] reported BMD results of the calca-
neus in children with different GMFCS levels (Tables 3 and 4). In a
group with GMFCS levels I and II combined, Wilmshurst et al. [36]
and Chen et al. [30] reported no low BMD regarding Z-score-
2.0. However, Wilmshust et al. [36] reported a Z-score of
1.07, SD 1.0, p< 0.01. Likewise, no low BMD was reported
regarding Z-score2.0 in the GMFCS level III group, but the
studies by Wilmshurst et al. [36] (Z-score 1.85, SD 1.0, p< 0.05)
and Chen et al. [30] (Z-score 1.71, SD 0.7, p< 0.001) reported
low BMD regarding Z-score1.0. According to the best-evi-
dence synthesis regarding Z score2.0, there was no evidence
for low BMD of the calcaneus in children in a combined group
with GMFCS levels I and II or GMFCS level III group. According to
the best-evidence synthesis regarding Z-score1.0, there was
conflicting evidence for low BMD of the calcaneus in children in a
combined group with GMFCS level I and II. In addition, there was
moderate evidence for low BMD of the calcaneus in children with
GMFCS level III.
We found no studies regarding BMD of the calcaneus in adults
(GMFCS I–III) (Tables 5 and 6).
Radius
The low-quality study of Hartman et al. [43] reported BMD results
of the radius in a sample of persons up to 29 years of age with
GMFCS levels I and II (Tables 3 and 5). According to Z-score-
2.0, no low BMD was reported for GMFCS level I (Z-score –1.7,
SD 0.5, p< 0.01) or GMFCS level II. According to the best-evidence
synthesis regarding Z-score2.0, there was no evidence for low
BMD of the radius in a group of children and adults up to 29 years
of age with GMFCS level I or GMFCS level II. According to the
best-evidence synthesis regarding Z-score1.0, there was lim-
ited evidence for low BMD of the radius in a group of children
and adults up to 29 years of age with GMFCS level I and no evi-
dence for GMFCS level II.
Tibia
The low-quality study by Hartman et al. [43] reported BMD results
for the tibia in a sample that included persons aged 1–29 years
with GMFCS levels I and II (Tables 3 and 5). No low BMD was
reported, not regarding Z-score2.0 nor regarding Z-score-
1.0 in GMFCS level I or GMFCS level II. According to the best-
evidence synthesis regarding Z-score2.0 and Z1.0, there
was no evidence for low BMD of the tibia in a combined group of
children and adults up to 29 years of age with GMFCS level I and
GMFCS level II.
Total body
Two high-quality studies [37,42] reported BMD results of the total
body for children with different GMFCS levels (Tables 3 and 4).
Regarding Z-score2.0, for GMFCS level I, Finbråten et al. [37]
reported no low BMD (Z-score 1.5, SD 0.9, p< 0.001). However,
the same study showed low BMD for GMFCS level II (Z-score 2.2,
SD 1.1, p< 0.001). In a group combining GMFCS levels I and II,
Chad et al. [42] reported no low BMD. According to the best-evi-
dence synthesis regarding Z-score2.0, there was moderate evi-
dence for low BMD of the total body for children with GMFCS
level II. There was no evidence for low BMD of the total body in
children with GMFCS level I or in a combined group with GMFCS
levels I and II. According to the best-evidence synthesis regarding
Z-score1.0, there was moderate evidence for low BMD of the
total body in children with GMFCS levels I and II and no evidence
for BMD of the total body in a combined group with GMFCS lev-
els I and II.
Table 6. Bone mineral density results for adults.
Measurement location GMFCS Study Z-score (SD) p value
Proximal femur
Total proximal femur I–II Fowler [38] 0.86 (1.0) <0.01a
III Fowler [38] 1.23 (0.9) <0.01a
I–II–III (spastic) Kim [34] 1.2 (1.0) ¼0.001a
I–II–III (dyskinetic) Kim [34] 0.4 (1.0) >0.05a
Femur neck I–II Fowler [38] 0.75 (1.1) <0.05a
III Fowler [38] 0.54 (1.5) >0.05a
I–II–III (spastic) Kim [34] 0.7 (0.9) <0.05a
I–II–III (dyskinetic) Kim [34] 0.2 (1.0) >0.05a
Lumbar spine
Not reported I–II Fowler [38] 1.07 (1.0) <0.001a
III Fowler [38] 0.98 (0.8) <0.01a
L1–L4 I–II–III (spastic) Kim [34] 0.9 (1.3) <0.05a
I–II–III (dyskinetic) Kim [34] 0.1 (1.1) >0.05a
L4 I–II–III (cortical) Peterson [39] 0.69a (1.1a) <0.05a
I–II–III (trabecular) Peterson [39] 0.56a (1.1a) <0.05a
aCalculated based on mean, standard deviation and sample size; studies indicated with a  demonstrate a high quality study. Additional Z-
score1.0 are in italics; GMFCS: Gross Motor Function Classification System [18].
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We found no studies regarding BMD of the total body in chil-
dren with GMFCS III and in adults (GMFCS I–III) (Tables 5 and 6).
Discussion
According to our primary best-evidence synthesis regarding a Z-
score2, which follows the International Society For Clinical
Densitometry [6,27], we found moderate evidence for low BMD of
the total proximal femur in children with GMFCS III and of the
total body in children with GMFCS level II. Furthermore, we found
conflicting evidence for low BMD of the distal femur in children
with GMFCS level II and of the lumbar spine in children with
GMFCS level III. We found no evidence for low BMD in children
with GMFCS I, in adults, or in other parts of the body. However, Z-
scores1 were found in several parts of the body and in several
groups. Although this cutoff value is not in accordance with the
criteria of the International Society for Clinical Densitometry [6,27],
it may indicate a tendency towards low BMD and may be clinically
important considering timely prevention. In addition, it is
unknown whether BMD Z-score>2 is associated with more fra-
gility or increased fracture risk [6,27].
The moderate evidence we found for low BMD of the total
proximal femur in children with GMFCS level III is consistent with
our expectations, as the duration and number of standing and
walking activities decreases with worsening gross motor function-
ing [9]. In contrast, there was no evidence for low BMD of the
total proximal femur for adults with GMFCS level III. However, the
best-evidence synthesis regarding Z-score1.0 suggests a ten-
dency towards low BMD of the total proximal femur in adults
with GMFCS level III. In addition, this secondary analysis showed
limited evidence for a tendency towards low BMD of the total
proximal femur in a combined group of adults with spastic type
CP with GMFCS I–II–III.
The finding of moderate evidence for low BMD of the total
body in children with GMFCS II was surprising, because we did
not find evidence for low BMD in children with GMFCS II in most
parts of the body except for the distal femur (conflicting evidence,
same result for the best-evidence synthesis regarding Z-score-
1.0). This finding of conflicting evidence for the distal femur
was also remarkable because we found no evidence for low BMD
in the same region in children with GMFCS level III .However, the
best-evidence syntheses regarding Z-score1 pointed at a ten-
dency towards low BMD in several groups and in several regions,
which may explain the above discrepancy.
Several studies explored BMD in non-ambulatory persons with
CP (GMFCS IV–V), [3,16,17,30,32,35,37,44]. These studies focused
primarily on BMD of the femur and lumbar spine in children, and
generally showed that low BMD is a serious problem in children
with severe CP [3,16,17,32,42]. The BMD Z-score in these studies
ranged from 2.4 to 3.8 for the femur and from 1.8 to 2.2
for the lumbar spine. Compared with these studies, the average
BMD deficits we found in ambulatory persons with CP were less
severe. It is worth mentioning that this study focuses on mean Z-
scores from various studies, while variability between subjects
within a study exists, as some individuals will have lower Z-scores
than the mean while others will have higher scores. Our findings
are in line with our expectations, as nutritional problems, epilepsy,
and inactivity (including fewer weight-bearing activities) occur less
frequently in ambulatory persons with CP [9,10,19,30,38].
For non-ambulatory children at risk for low BMD, regular BMD
evaluation and vitamin D and calcium intake optimization is
advised [16]. One might argue to also use a similar strategy in
ambulatory children with CP (particularly for GMFCS II and III).
However, although nutritional adaptations may improve BMD, it is
yet unclear whether this results in fewer fractures [45]. It is also
unclear to what extent nutritional problems and medication deter-
mine low BMD in ambulatory persons with CP. Given the generally
low activity levels in ambulatory persons with CP, a more active
lifestyle with more weight-bearing activities is a potential strategy
to improve BMD as well. Because the literature on BMD in ambu-
latory persons with CP, particularly adults, is scarce, more research
is required before specific recommendations can be made for
treatment in this population. Future research should also address
fracture risk because the literature on the relationship between
low BMD and fractures is limited and conflicting, and is primarily
based on retrospective self-reports [12,46,47].
The strength of our systematic review is that we retrieved and
combined data from available studies on BMD from various coun-
tries. However, some limitations should be mentioned: (1) dual X-
ray absorptiometry was the most frequently used method for
measuring BMD, but other methods were also used. The
International Society for Clinical Densitometry stated in 2013 that
dual X-ray absorptiometry is the preferred method for clinical
densitometry evaluation in children and adults [27]. However, the
dual X-ray absorptiometry scan has limitations. The bone is a
three-dimensional structure that is measured two-dimensionally
by dual X-ray absorptiometry; this can lead to underestimation of
BMD in small bones and overestimation of BMD in large bones
[26,48–50]. The QCT measures volumetric BMD but, because of
limited reference data and higher radiation dose, this method is
not regularly used [26,48,49]. There are also limited reference data
for ultrasound. (2) Muscle and joint contractures may have influ-
enced BMD measurements. McDowell et al. [51] reported a signifi-
cant reduction of the passive range of motion with increasing
functional limitation. Scoliosis and metallic implants may also
have limited BMD measurements. The risk of developing scoliosis
also increases with increasing functional limitations [52]. (3) In
most studies, participants were recruited from only one hospital
or rehabilitation center, which may have resulted in selection bias.
Only the high-quality study of Henderson et al. [3] included partic-
ipants from multiple centers. Furthermore, studies focused primar-
ily on children. (4) Because of the heterogeneity of CP, we
decided to present the evidence as much as possible by GMFCS
level. This grouping often resulted in small sample sizes per level.
Because not all studies used the GMFCS classification, we had to
infer GMFCS level in some studies. (5) Some research groups have
published several articles on BMD, so we had to use our own
judgment regarding study inclusion in those cases. (6) Most stud-
ies did not focus on differences in BMD between ambulatory per-
sons with CP (GMFCS I–III) and typically developing persons, but
on differences between persons with CP across all GMFCS levels,
including non-ambulatory persons, and typically developing per-
sons. Therefore, we had to calculate significance levels for several
studies. (7) Finally, five of the included studies only presented
average BMD (SD) levels in persons with CP and typically develop-
ing persons. Thus, we had to calculate average (SD) Z-score from
these data. Because we only included studies containing a typic-
ally developing group 15 persons, we expect only a minor effect
of this procedure on our conclusions.
In conclusion, we found moderate and conflicting evidence for
low BMD of several body parts (total proximal femur, total body,
distal femur, and lumbar spine) in children with GMFCS II and III.
This suggests that mainly children with GMFCS II and III are vul-
nerable to low BMD. However, the results of the secondary best-
evidence syntheses for Z-score1.0, suggest a tendency
towards low BMD in other regions than the above in children
with GMFCS II and III and also in children with GMFCS I and
adults. Although more high-quality research is needed, including
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adults and fracture risk assessment, the current study indicates
that deficits in BMD are not restricted to non-ambulatory people
with CP.
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